Indeed, a recent report which re-examined multiple antibodies used to measure the prolactin receptor in human breast cancer, concluded that most of the antibodies cross-reacted with other proteins such as cytokeratin 18 [33]. This evidence concerns the gene KRT18 and breast cancer.